HR Execs on the Move

Ancora Heart

www.ancoraheart.com

 
We are a medical device company based in Santa Clara, CA, dedicated to helping people with heart failure and functional mitral regurgitation (FMR) feel better and live longer.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Mark Miles
Chief Commercial Officer Profile
Jeff Closs
President and Chief Executive Officer Profile

Similar Companies

Advanced Medical Equipment Inc

Advanced Medical Equipment Inc is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

MicroAire

MicroAire is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Southeast Michigan Surgical Hospital

Southeast Michigan Surgical Hospital is a Warren, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ConvaTec

ConvaTec is a global medical products and technologies company with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Our brands include AQUACEL® advanced wound dressings, which form a gel on contact with wound fluid, creating an optimal environment for wound healing. ConvaTec has more than 9,000 employees with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners.

Reva Medical

Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage its proprietary biomaterial and stent technologies to improve the treatment of coronary artery disease. Guided by an executive management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of a drug-eluting bioresorbable coronary scaffold to advance the treatment of cardiovascular disease, the leading cause of death worldwide.